Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a common numbing drug speed up gallbladder surgery recovery?

NCT ID NCT07150481

Symptom relief Sponsor: Assiut University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether giving lidocaine through an IV during gallbladder surgery can reduce inflammation and pain, and help the gut start working again sooner. 90 adults having planned laparoscopic gallbladder removal will be randomly assigned to receive either lidocaine or a placebo. The main goal is to see if lidocaine lowers C-reactive protein (a marker of inflammation) after surgery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
lidocaine
What this could lead to
If it works, this could offer a simple, low-cost way to reduce pain and inflammation after gallbladder surgery, helping patients recover faster.
What could go wrong
This is a small, early-phase trial. Lidocaine may not significantly improve recovery, and there are risks like allergic reactions or side effects from the infusion.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2/3

Runs two stages together: whether the treatment works, then large-scale confirmation.

Participants

About 90 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2025

An estimate. Start dates often move.

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Patients aged 18 - 60 years 2. Elective laparoscopic cholecystectomy for symptomatic cholelithiasis or chronic cholecystitis 3. ASA physical status I-II 4. BMI \< 35 kg/m2 5. Preoperative CRP \<20 mg/L 6. Informed consent provided Exclusion Criteria: 1. Acute cholecystitis or biliary pancreatitis 2. Conversion to open surgery 3. Pre-op CRP \>20 mg/L 4. Allergy to lidocaine or local anesthetics 5. Known hepatic or renal dysfunction 6. Chronic inflammatory conditions 7. Current immunosuppressive therapy 8. Cardiac arrhythmias or heart block without pacemaker 9. ASA physical status III, IV or above 10. Pregnancy or breastfeeding 11. Psychiatric disorders

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic cholecystitis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cholecystitis cholelithiasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Enhanced recovery after anesthesia

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Assiut university main hospital

    Asyut, Assiut Governorate, Egypt,, 71515, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.